Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by Resilience19on Jun 22, 2023 9:55am
174 Views
Post# 35508910

RE:RE:Time to get on marketing.

RE:RE:Time to get on marketing.In response to the various questions raised:

  • Is DM  undervalued? This is increasingly difficult to assess as C-19 income has come to an end and that the last contract announcement was in early February (3.5 months ago)
  • Does the future looks bright? A number of interesting initiatives are on the way but none has meaningfully gained traction yet, including eHealth which started 2 years ago, dmEVS which started last year and AnalyticsGPT which has been piloted since March. Besides this no new NexaSMART contract has been announced in a while and, despite IDEaS Milestone 2 having been announced as having come to an end (early April?) we still have no clue as to the true income that 12 month milestone will have generated. So, yes, the future notionally looks bright but without real data it's becoming increasingly difficult to assess the future;
  • Are Insiders heavily selling? Not meaningfully BUT they've, only 2 weeks ago, been given HUGE options incentives at close to DM's past years historically low sp. In short, I think their bets have been hedged, contrary to retail investors;
  • Is DM Fundamentily improving itself? In terms of diversification, yes, although the proof will be in the pudding (i.e. I'm yet to be convinced that the eHealth and dmEVS verticals will generate as much income as if DM had, rather, pursued a purer NexaSMART/AnalyticsGPT-type approach and kept a larger portion of its C-19 generated cash).
  • Is it a good time to accumulate or should potential investers wait till news brings DM to .12 /.15 before jumping in? Well, if I'd been given a stash of stock options at 0.08 I'd certainly be content with accumulating but, at this point, given the rather LONG anaemic sp stint and lack of concrete contracts/income news, I'm not sure chipping in more of DM at 0.08 is a better bet than other businesses, which may be demonstrating more short term positive sp potential.
I don't mean to sound pessimistic but the lack of what I consider to be concrete news, of the past months, alongside a relentlessly declining or moribond sp, increasingly make it difficult to update DM's DD. In turn, this leads to negative sentiment - noting that leading into the former part of Q2 2023 I remained rather positive but am now looking at hedging my bets a bit more.

My two cents

<< Previous
Bullboard Posts
Next >>